Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2165 SEK | +4.09% | -40.52% | -97.83% |
Apr. 22 | Transcript : Xbrane Biopharma AB - Special Call | |
Mar. 18 | Xbrane Biopharma AB(OM:XBRANE) dropped from S&P Global BMI Index | CI |
Business Summary
Number of employees: 93
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 58 | 100.0 % | 239 | 100.0 % | +314.33% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Europe
88.0
%
| 7 | 11.6 % | 210 | 88.0 % | +3,034.33% |
North America
12.0
%
| 51 | 88.4 % | 29 | 12.0 % | -43.61% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Martin Åmark
CEO | Chief Executive Officer | 44 | 14-12-31 |
Anette Lindqvist
DFI | Director of Finance/CFO | 63 | 21-01-10 |
Dina Jurman
CTO | Chief Tech/Sci/R&D Officer | 42 | 17-10-08 |
David Vikström
CTO | Chief Tech/Sci/R&D Officer | 47 | 13-12-31 |
Siavash Bashiri
COO | Chief Operating Officer | 41 | 14-12-31 |
Nina Ivers
HRO | Human Resources Officer | 54 | 20-12-15 |
Xiaoli Hu
PRN | Corporate Officer/Principal | 42 | 20-04-30 |
Maria Edebrink
LAW | General Counsel | 55 | 18-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 14-12-31 | |
Director/Board Member | 70 | 14-12-31 | |
Director/Board Member | 53 | 19-12-31 | |
Eva Nilsagård
BRD | Director/Board Member | 60 | 19-05-15 |
Director/Board Member | - | 19-05-15 | |
Kirsti Gjellan
BRD | Director/Board Member | 61 | 22-05-04 |
Chairman | 63 | 18-04-02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,520,328,564 | 1,354,772,490 ( 89.11 %) | 0 | 89.11 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-97.83% | 29.21M | |
+0.64% | 43.84B | |
+4.73% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+5.84% | 25.53B | |
-25.63% | 18.18B | |
-3.88% | 12.29B | |
+25.31% | 12.29B | |
+6.84% | 11.15B |
- Stock Market
- Equities
- XBRANE Stock
- Company Xbrane Biopharma AB